21Oct
20Oct
Lia Winter invented Easy Whip and co-founded Winter Innovations while in school
Lia Winter invented Easy Whip and co-founded Winter Innovations while in school. Their innovative suturing two-part needle has already helped hundreds of patients with more successful and more efficient surgeries. We are so proud of the incredible work of Lia and Winter Innovations, and we can't wait to see them continue to succeed. Watch now >>
19Oct
EarthGrid PBC Seed Funding Oversubscribed
Today, EarthGrid Public Benefit Corporation (EarthGrid PBC), a plasma boring technology and infrastructure development company, is announcing it has raised $30 million at the close of its seed funding, doubling the investment goal of $15 million. This brings the total equity raised by EarthGrid to approximately $50 million since its inception in 2016. The $30 million will enhance the production of Tunnel Boring Robots (TBRs) which utilize a series of plasma-powered torches to break down geologic structures. The TBRs will...
19Oct
AAOpt 2023: A look into eSight’s wearable technologies
Roland Mattern and Gary Foster caught up with Optometry Times during the 2023 American Academy of Optometry meeting in New Orleans to share what's new with eSight. Roland Mattern:Hi there, I'm Roland Mattern, Director of Sales Marketing for eSight. Gary Foster: I'm Gary Foster. I've been wearing eSight since 2015. We're at AAO in New Orleans 2023, showcasing our wearable technologies simply designed for central vision loss and low vision patients. The eSight Go features a wider field of view...
19Oct
Pixability Launches First-of-its-Kind DE&I Solution to Ensure Investment in Diverse Communities and Give Creators a Voice and Choice about Which Communities they Represent
Pixability, (www.pixability.com), the leader in brand suitability and contextual targeting solutions for advertisers on YouTube, today announced the launch of its Inclusive Media Initiative. For the first time, creators will now be able to self-identify the communities that they represent and advertisers will be able to direct their advertising accordingly to the largest network of self-identified diverse creators available. As a result, advertisers can feel confident they are supporting the communities they want to reach while driving greater representation and...
18Oct
CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy
CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it has initiated recruitment and will enroll its first patient at UPMC Hillman Cancer Center, in the Phase 1b/2a clinical trial evaluating the therapeutic, CTO1681, to treat CRS in lymphoma patients receiving CAR T-cell Therapy. “This clinical trial (CTA-2101) addresses an area of great unmet medical need as the majority of patients receiving CAR T-cell Therapy experience the toxicities of CRS...
10Oct
Marketing enters its digital renaissance
A major movement as part of the Renaissance era, Humanism is defined by scholars as an intellectual movement in which people began to view themselves as the center of their own universe and embrace human achievements. Today, many might note that marketing has entered its renaissance as digital solutions have allowed brands to take their engagement with consumers to another level. The Elizabeth Banks Book Club campaign from Archer Roose directed consumers to the brand’s Instagram page to join “the...
08Oct
5 Kinds of Tech Designed to Support People With Disabilities
From voice assistants and smart home devices to smart hearing aids and more, technology is improving accessibility in a variety of ways. Technology may often be flashy and futuristic, but it's also grown in areas of accessibility and inclusivity. For people with disabilities, tech tools are not mere conveniences, they are gateways to a more accessible world. Partial vision? No problem. AR glasses like the eSight or Orcam MyEye are saving the day. They can magnify and clarify visual details,...
07Oct
RevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures
RevBio, Inc., announced that it has been awarded a grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), through its Commercialization Readiness Program of up to $3.4 million over the next three years (1SB1AG085803-01). This grant will enable the company to finish its late-stage product development activities and conduct a clinical trial to demonstrate the safety and efficacy of the product in comparison to the current standard of care. Read more >>
04Oct